Olof Eriksson
Overview
Explore the profile of Olof Eriksson including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
104
Citations
1363
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wilske F, Eriksson O, Amini R, Estrada S, Janols H, Khalil A, et al.
Intensive Care Med Exp
. 2025 Feb;
13(1):14.
PMID: 39904820
Background: Neutrophil granulocytes are important parts of the defence against bacterial infections. Their action is a two-edged sword, the mediators killing the intruding bacteria are at the same time causing...
2.
Cheung P, Persson J, Zhang B, Vasylovska S, Lau J, Invast S, et al.
Sci Rep
. 2025 Jan;
15(1):417.
PMID: 39747317
A distinctive feature of both type 1 and type 2 diabetes is the waning of insulin-secreting beta cells in the pancreas. New methods for direct and specific targeting of the...
3.
Maloum-Rami F, Cheung P, Antoni G, Jin Z, Eriksson O, Espes D
EJNMMI Res
. 2024 Dec;
14(1):122.
PMID: 39623212
Background: Type 1 diabetes (T1D) is an autoimmune disease characterized by a progressive β-cell destruction. There are no clinically established methods for quantifying endocrine cells of the pancreas and current...
4.
Lechi F, Eriksson J, Odell L, Wegrzyniak O, Lofblom J, Frejd F, et al.
EJNMMI Radiopharm Chem
. 2024 Oct;
9(1):73.
PMID: 39460878
Background: In recent years, the interest in Al[F]F as a labeling agent for Positron Emission Tomography (PET) radiotracers has risen, as it allows for fast and efficient fluorine-18 labeling by...
5.
Boss M, Eriksson O, Mikkola K, Eek A, Brom M, Buitinga M, et al.
J Nucl Med
. 2024 Oct;
65(12):1959-1964.
PMID: 39419553
Precise anatomic localization of insulinomas is crucial for surgical treatment. Current routine noninvasive imaging techniques, including CT, MRI, and Ga-DOTA-somatostatin analog (DOTA-SSA) PET/CT, have limited sensitivity. Endoscopic ultrasound is highly...
6.
Liggieri F, Chiodaroli E, Pellegrini M, Puuvuori E, Sigfridsson J, Velikyan I, et al.
Intensive Care Med Exp
. 2024 Sep;
12(1):77.
PMID: 39225817
Background: Alveolar macrophages activation to the pro-inflammatory phenotype M1 is pivotal in the pathophysiology of Ventilator-Induced Lung Injury (VILI). Increased lung strain is a known determinant of VILI, but a...
7.
Wegrzyniak O, Lechi F, Mitran B, Cheung P, Bitzios A, Persson J, et al.
iScience
. 2024 Apr;
27(5):109688.
PMID: 38660405
Non-invasive assessment of fibrogenic activity, rather than fibrotic scars, could significantly improve the management of fibrotic diseases and the development of anti-fibrotic drugs. This study explores the potential of an...
8.
Khalil A, Hakhverdyan S, Cheung P, Bossart M, Wagner M, Eriksson O, et al.
Nucl Med Biol
. 2024 Jan;
128-129:108876.
PMID: 38241936
Background: The beneficial role of glucose-dependent insulinotropic polypeptide receptor (GIPR) in weight control and maintaining glucose levels has led to the development of several multi-agonistic peptide drug candidates, targeting GIPR...
9.
Cheung P, Thorngren J, Zhang B, Vasylovska S, Lechi F, Persson J, et al.
EJNMMI Res
. 2023 Dec;
13(1):107.
PMID: 38100042
Background: Beta-cell replacement methods such as transplantation of isolated donor islets have been proposed as a curative treatment of type 1 diabetes, but widespread application is challenging due to shortages...
10.
Puuvuori E, Shen Y, Hulsart-Billstrom G, Mitran B, Zhang B, Cheung P, et al.
J Nucl Med
. 2023 Dec;
65(2):294-299.
PMID: 38050119
Rheumatoid arthritis (RA) is the most common inflammatory joint disease, and early diagnosis is key for effective disease management. CD69 is one of the earliest cell surface markers seen at...